Press Release:  Latest Advances in Vaccine Development by Top Panel Speakers at Cartagena, Colombia   |   Final Program   |   Submit Presentation   |   Photo Gallery-2016

co-organisers

UNIVERSIDAD DE CIENCIAS
APLICADAS Y AMBIENTALES

COLCIENCIAS
COLOMBIA

FIDIC
COLOMBIA

UNIVERSIDAD DEL ROSARIO
COLOMBIA

LIMOR LABORATORIES
COLOMBIA



Keynote Speakers

Nancy Sullivan

Nancy Sullivan
Chief, Biodefense Research Section, Vaccine Research Center, NIH USA

Manuel Elkin Patarroyo

Manuel Elkin Patarroyo M.
Fundacion Instituto De Inmunologia De Colombia - FIDIC

Christian Griesinger

Christian Griesinger
Max-Planck Institute for Biophysical Chemistry
Germany

Kwadwo Ansah KORAM

Kwadwo Ansah KORAM
Director, Noguchi Memorial Institute for Medical Research (NMIMR)
Ghana



scientific sessions

01

Cancer vaccines

Influenza vaccines/virus

Novel vaccines

02

Clinical trials

Human vaccines infectious & non-infectious diseases

Passive vaccines-therapeutic antibodies against infectious diseases

03

HIV/AIDS vaccines

HPV vaccines

Bioprocessing & Manufacturing

04

Therapeutic vaccination for auto immune diseases

New vaccines

Veterinary vaccines

Vaccines R&D-2015 Participants

our price

Early Bird

  • Access to main conference sessions, exhibits, poster sessions and round table discussions

  • Conference material

  • Tea / Coffee breaks, lunch during the conference days

  • Reception or Dinner

After Early Bird

  • Access to main conference sessions, exhibits, poster sessions and round table discussions

  • Conference material

  • Tea / Coffee breaks, lunch during the conference days

  • Reception or Dinner

On Spot Registration

  • Access to main conference sessions, exhibits, poster sessions and round table discussions

  • Conference material

  • Tea / Coffee breaks, lunch during the conference days

  • Reception or Dinner

 

Cancellation policy


Cancellation policy is strictly followed and all cancellations must be made in writing. Before sixty days will receive a full refund, less a $100 towards administrative fee. Cancellations received after close of business [before one month of the conference start date] are non-refundable.
In this case if the applicant is author, the paper will still be published in the conference proceedings and delegates will receive an electronic copy of the proceedings.
Refunds will be made within 28 days of receipt of cancellation notification.

Testimonials

  • Manuel Elkin Patarroyo

    Excellent organization of the event; Congratulations

  • Robert W Malone

    Good hospitality of the organizers, plenary session are very good value and excellent job for first conference

  • Osama Rahma

    Good Collaboration experts in the field

  • Shahin Gharakhanian

    Overall program very comprehensive, Symposium was good

  • Yahia CHEBLOUNE

    Conviviality contact and discussions

  • María Marcela Barrio

    Keynote sessions were very good

  • Sushma Kommareddy

    All the talks were really good there is never a dull moment

  • Jane Homan

    20min time slot's overall very good program

  • Peter J Holst

    Occasional scientific gems, good keynote presentations and meeting local scientific collaborators

  • Nabil Al-Humadi

    Lovely certificate, very good meeting

blog

Report on the International Conference on Vaccines Research & Development (Vaccines R&D-2015

04-Dec-15 by United Scientific Group

The first International Conference on Vaccines Research & Development (Vaccines R&D-2015) concluded successfully on November 04, 2015. The three-day conference organized by United Scientific Group (USG) during November 02-04, 2015 at DoubleTree by Hilton, Baltimore BWI airport hotel with the theme "A New Era in Vaccine Discovery"

GenVec Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference

10-Nov-15 by GenVec

GenVec, Inc. (NASDAQ: GNVC), a clinical-stage gene delivery company, announced that Douglas E. Brough, Ph.D., the company’s chief scientific officer, has given a presentation entitled “Gorilla Adenovirus Vectors for Molecular Therapeutics and Vaccines” at the Vaccines R&D-2015 Conference in Baltimore taking place November 2-4, 2015

VLP Therapeutics to Present at International Conference on Vaccines R&D 2015

10-Nov-15 by VLP Therapeutics

Gaithersburg-based biotechnology company focusing on the research and development of therapeutic and preventative vaccines and next generation antibody agents based upon a novel and proprietary vaccine technology, announced that its Chief Executive Officer, Dr. Wataru Akahata, will present at the International Conference on Vaccines Research and Development 2015 on Tuesday, November 3, 2015

Groundbreaking Lineup of Keynote and Featured Speakers for Vaccines Research & Development Conference

12-Oct-15 by United Scientific Group

United Scientific Group is pleased to announce the groundbreaking lineup of keynote and featured speakers for Vaccines Research & Development Conference taking place during November 2-4, 2015 at DoubleTree by Hilton Baltimore-BWI Airport (Vaccines R&D-2015).

collaboration partners

The relationship between infection with Zika virus and primary microcephaly meets most accepted criteria for causality, and it has become clear that Zika infection during pregnancy is associated with a cluster of birth defects known as Zika Fetal Syndrome.

Atheric Pharmaceutical LLC ("Atheric(tm)") is a biopharmaceutical company focused on the rapid development and commercialization of re-purposed drugs to prevent and treat Zika and other Flavivirus disease.

location

contact form

name *
email address *
subject *
message *

Hotel Address & Convention Center

Hotel Las Americas International Convention And Exhibition Center

Anillo Vial Cielo Mar Sector

Cartagena 1082, Colombia

Phone: +57 (5) 672 3344 / 57 (5) 672 4242

Toll free: 01-8000-953-777